Mutation analysis using cell-free DNA for endocrine therapy in patients with HR+ metastatic breast cancer.

The presence of mutations in ESR1 or PIK3CA was an important predictive factor for shorter TTP1, although the values did not reach statistical significance when adjusting for other clinical variables (Table S3 ).

also in 111,027 other papers